Terns Pharmaceuticals Inc... (TERN)
NASDAQ: TERN
· Real-Time Price · USD
3.75
-0.08 (-2.09%)
At close: Jun 30, 2025, 3:59 PM
3.79
1.20%
After-hours: Jun 30, 2025, 06:03 PM EDT
-2.09% (1D)
| Bid | 3.76 |
| Market Cap | 327.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -90.39M |
| EPS (ttm) | -1.08 |
| PE Ratio (ttm) | -3.47 |
| Forward PE | -3.31 |
| Analyst | Buy |
| Ask | 4.1 |
| Volume | 501,393 |
| Avg. Volume (20D) | 1,025,543 |
| Open | 3.85 |
| Previous Close | 3.83 |
| Day's Range | 3.74 - 3.95 |
| 52-Week Range | 1.86 - 11.40 |
| Beta | -0.19 |
About TERN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TERN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TERN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-5.64%
TERN stock has given up its prior gain. Terns Phar...
Unlock content with
Pro Subscription
1 week ago
-5.64%
Terns Pharmaceuticals shares are trading higher after the company announced it will highlight data from the completed Phase 1 study of TERN-601 at the American Diabetes Association 85th Scientific Sessions. Also, the company completed enrollment for the Phase 2 FALCON trial.
2 weeks ago · https://www.defenseworld.net
Squarepoint Ops LLC Has $73,000 Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)Squarepoint Ops LLC cut its holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 75.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institu...
